Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-26 @ 5:45 AM
Study NCT ID:
NCT00736060
Status:
COMPLETED
Last Update Posted:
2011-08-26
First Post:
2008-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
Sponsor:
HaEmek Medical Center, Israel
Organization:
Study Overview
Official Title:
Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom
Status:
COMPLETED
Status Verified Date:
2011-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
Detailed Description:
The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.
The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.
The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: